Related Experiment Video
Updated: Jul 23, 2025

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
Published on: February 16, 2024
Risk Prediction Model for Crohn's Disease Based on Hematological Indicators
Insights
A new model using routine blood tests predicts Crohn's disease (CD) risk. This tool aids in early diagnosis and differentiating CD from conditions like intestinal tuberculosis (ITB).
Area of Science:
- Gastroenterology
- Internal Medicine
- Diagnostic Medicine
Background:
- Diagnostic errors are common when distinguishing Crohn's disease (CD) from other conditions like ulcerative colitis (UC) and intestinal tuberculosis (ITB).
- An efficient, rapid, and simple predictive model is crucial for clinical application in CD diagnosis.
- Current diagnostic methods can be invasive and time-consuming, necessitating simpler alternatives.
Purpose of the Study:
- To develop a risk prediction model for CD using five routine laboratory tests.
- To create an early warning system and a visual nomograph for CD risk assessment.
- To provide clinicians with a convenient tool for CD risk determination and differential diagnosis.
Main Methods:
- Retrospective analysis of 310 cases (2020-2022) including CD, UC, non-IBD diseases, and healthy controls.
- Risk prediction models were built using logistic regression based on hematological indices: ESR, Hb, WBC, ALb, and CH.
- Models were evaluated for diagnostic accuracy and visualized using a nomograph.
Main Results:
- Significant differences in ESR, WBC, and WBC/CH ratios were observed between CD and non-CD groups (p < 0.05).
- The WBC/CH ratio showed a strong correlation with CD occurrence (correlation coefficient > 0.4).
- A logistic regression model demonstrated high diagnostic accuracy (AUC=0.86) for CD prediction and (AUC=0.88) for differentiating CD from ITB.
Conclusions:
- A novel CD risk prediction model was successfully established using five conventional hematological indices.
- The model, visualized via a nomograph, offers high diagnostic accuracy for CD and its differentiation from ITB.
- This tool can assist clinicians in better managing CD and reducing patient suffering.
Background:
The similarity between Crohn's disease (CD) and non-CD, especially with ulcerative colitis (UC) or intestinal tuberculosis (ITB), makes the diagnostic error rate not low. Therefore, there is an urgent need for an efficient, fast, and simple predictive model that can be applied in clinical practice. The purpose of this study is to establish the risk prediction model for CD based on five routine laboratory tests by logistic-regression algorithm, to construct the early warning model for CD and the corresponding visual nomograph, and to provide an accurate and convenient reference for the risk determination and differential diagnosis of CD, in order to assist clinicians to better manage CD and reduce patient suffering.
Methods:
Using a retrospective analysis, a total of 310 cases were collected from 2020 to 2022 at The Sixth Affiliated Hospital, Sun Yat-sen University, who were diagnosed by comprehensive clinical diagnosis, including 100 patients with CD, 50 patients with ulcerative colitis (UC), 110 patients with non-inflammatory bowel disease (non-IBD) diseases (65 cases of intestinal tuberculosis, radioactive enterocolitis 39, and colonic diverticulitis 6), and 50 healthy individuals (NC) in the non-CD group. Risk prediction models were established by measuring ESR, Hb, WBC, ALb, and CH levels in hematology. The models were evaluated and visualized using logistic-regression algorithm.
Results:
1) ESR, WBC, and WBC/CH ratios in the CD group were higher than those in the non-CD group, while ALb, Hb, CH, WBC/ESR ratio, and Hb/WBC ratio were lower than those in the non-CD group, and the differences were statistically significant (all p < 0.05). 2) CD occurrence had a strong correlation with the WBC/CH ratio, with the correlation coefficient exceeding 0.4; CD occurrence was correlated with other indicators. 3) A risk prediction model containing age, gender, ESR, ALb, Hb, CH, WBC, WBC/CH, WBC/ESR, and Hb/WBC characteristics was constructed using a logistic-regression algorithm. The sensitivity, specificity, positive predictive value, negative predictive value, and area under the curve of the model were 83.0%, 76.2%, 59.0%, 90.5%, and 0.86, respectively. The model based on the corresponding index also had high diagnostic accuracy (AUC = 0.88) for differentiating CD from ITB. Visual nomograph based on the logistic-regression algorithm was also constructed for clinical application reference.
Conclusions:
In this study, a CD risk prediction model was established and visualized by five conventional hema-tological indices: ESR, Hb, WBC, ALb, and CH, in addition to a high diagnostic accuracy for the differential diagnosis of CD and ITB.
More Related Videos
10:21Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin
Published on: September 12, 2019
09:04DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
Published on: February 27, 2014
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF